Abstract Objective To investigate the risk factors for diabetic ketoacidosis (DKA) in children/adolescents with type 1 diabetes mellitus (T1DM) and to establish a model for predicting the risk of DKA. Methods A retrospective analysis was performed on 217 children/adolescents with T1DM who were admitted to General Hospital of Ningxia Medical University from January 2018 to December 2021. Among the 217 children/adolescents,169 cases with DKA were included as the DKA group and 48 cases without DKA were included as the non-DKA group. The risk factors for DKA in the children/adolescents with T1DM were analyzed, and a nomogram model was established for predicting the risk of DKA in children/adolescents with T1DM. Results For the 217 children/adolescents with T1DM, the incidence rate of DKA was 77.9% (169/217). The multivariate logistic regression analysis showed that high levels of random blood glucose, hemoglobin A1c (HbA1c), blood ketone body, and triglyceride on admission were closely associated with the development of DKA in the children/adolescents with T1DM (OR=1.156, 3.203×1015, 20.131, and 9.519 respectively; P<0.05). The nomogram prediction model had a C-statistic of 0.95, with a mean absolute error of 0.004 between the risk of DKA predicted by the nomogram model and the actual risk of DKA, indicating that the model had a good overall prediction ability. Conclusions High levels of random blood glucose, HbA1c, blood ketone body, and triglyceride on admission are closely associated with the development of DKA in children/adolescents with T1DM, and targeted intervention measures should be developed to reduce the risk of DKA.
WANG Xiao-Jia,GONG Ai-Hong,QI Sheng-Hong et al. Risk factors for ketoacidosis in children/adolescents with type 1 diabetes mellitus and establishment of a predictive model[J]. CJCP, 2024, 26(1): 62-66.
WANG Xiao-Jia,GONG Ai-Hong,QI Sheng-Hong et al. Risk factors for ketoacidosis in children/adolescents with type 1 diabetes mellitus and establishment of a predictive model[J]. CJCP, 2024, 26(1): 62-66.
Chen Q, Xu N, Chen Y, et al. Incidence of newly diagnosed type 1 diabetes mellitus in children and adolescents in Henan province of China from 2017 to 2020: a retrospective multicenter study based on hospitalization data[J]. J Clin Res Pediatr Endocrinol, 2022, 14(3): 287-292. PMID: 35438270. PMCID: PMC9422922. DOI: 10.4274/jcrpe.galenos.2022.2022-12-4.
Peng W, Yuan J, Chiavaroli V, et al. 10-year incidence of diabetic ketoacidosis at type 1 diabetes diagnosis in children aged less than 16 years from a large regional center (Hangzhou, China)[J]. Front Endocrinol (Lausanne), 2021, 12: 653519. PMID: 33986725. PMCID: PMC8112199. DOI: 10.3389/fendo.2021.653519.
Cherubini V, Grimsmann JM, ?kesson K, et al. Temporal trends in diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes between 2006 and 2016: results from 13 countries in three continents[J]. Diabetologia, 2020, 63(8): 1530-1541. PMID: 32382815. PMCID: PMC7351855. DOI: 10.1007/s00125-020-05152-1.
Helminen O, Aspholm S, Pokka T, et al. HbA1c predicts time to diagnosis of type 1 diabetes in children at risk[J]. Diabetes, 2015, 64(5): 1719-1727. PMID: 25524912. DOI: 10.2337/db14-0497.
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group, Nathan DM, Zinman B, et al. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005)[J]. Arch Intern Med, 2009, 169(14): 1307-1316. PMID: 19636033. PMCID: PMC2866072. DOI: 10.1001/archinternmed.2009.193.
Osei K, Rhinesmith S, Gaillard T, et al. Is glycosylated hemoglobin A1c a surrogate for metabolic syndrome in nondiabetic, first-degree relatives of African-American patients with type 2 diabetes?[J]. J Clin Endocrinol Metab, 2003, 88(10): 4596-4601. PMID: 14557428. DOI: 10.1210/jc.2003-030686.
Wu Y, Tan W, Liu Y, et al. Development and validation of a nomogram prediction model for hypertension-diabetes comorbidity based on chronic disease management in the community[J]. Lipids Health Dis, 2023, 22(1): 135. PMID: 37620958. PMCID: PMC10463439. DOI: 10.1186/s12944-023-01904-1.
